Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:3244-3262
Published online before print June 8, 2009, doi: 10.1161/CIRCULATIONAHA.109.192521
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow All Versions of this Article:
119/25/3244    most recent
CIRCULATIONAHA.109.192521v2
CIRCULATIONAHA.109.192521v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Marwick, T. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marwick, T. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Diabetes
*Exercise for Children
*Exercise and Physical Fitness
Related Collections
Right arrow Secondary prevention
Right arrow Type 2 diabetes
Right arrow Exercise/exercise testing/rehabilitation

(Circulation. 2009;119:3244-3262.)
© 2009 American Heart Association, Inc.


AHA Scientific Statement

Exercise Training for Type 2 Diabetes Mellitus

Impact on Cardiovascular Risk: A Scientific Statement From the American Heart Association

Thomas H. Marwick, MD, PhD, Chair; Matthew D. Hordern, PhD; Todd Miller, MD, FAHA; Deborah A. Chyun, RN, PhD, FAHA; Alain G. Bertoni, MD, MPH, FAHA; Roger S. Blumenthal, MD, FAHA; George Philippides, MD; Albert Rocchini, MD, FAHA, on behalf of the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Nutrition, Physical Activity, and Metabolism; and the Interdisciplinary Council on Quality of Care and Outcomes Research


Key Words: AHA Scientific Statements • exercise • diabetes mellitus • prevention • risk factors


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 

  1. Introduction ...3244
  2. Beneficial Effects of Exercise in T2DM...3245
       Glycemic Control...3245
       Body Composition...3248
       Risk Factors...3248
       Vascular Effects...3248
       Myocardial Function...3248
       Development of CVD...3248

  3. Cardiac Risks of Exercise Training in T2DM...3249
       Generic Cardiac Risks of Training...3249
       Screening for Coronary Artery Disease...3249
       Prior Studies of CAD Screening...3249
       Guidelines/Position Statements...3250

  4. Noncardiac Risks of Exercise Training in T2DM...3251
       Hypoglycemia...3251
       Peripheral Arterial Disease and Foot Care...3251
       Microvascular Disease...3252

  5. Exercise Training Guidelines...3252
       Preparation for Exercise...3253
          Frequency...3253
          Intensity...3253

       Duration...3254
          Session Duration...3254
          Program Duration...3254

       Type...3254
          Aerobic...3254
          Resistance...3254


  6. Approaches to Adherence...3254
       Health Behavior...3254
       Counseling...3255
       Long-Term Efficacy...3255

  7. Special/Minority Groups...3255
  8. Conclusions...3256
  9. References...3257


*    1. Introduction
 
The increasing prevalence of overweight and obesity has led to an unprecedented epidemic of type 2 diabetes mellitus (T2DM)1–4 and is likely to be followed by an epidemic of patients with complications of T2DM.5 Given the observed increases in the prevalence of T2DM in adults over the past few decades in developed countries,1,2,6 population-based efforts to reduce the cardiovascular complications of T2DM are as critical as the measures to prevent the problem.4,7 T2DM is the sixth-leading cause of death,8 with most deaths attributed to cardiovascular disease (CVD; nearly 70%) and with ischemic heart disease being responsible for nearly 50% of these deaths.9 The economic cost of T2DM has been estimated to be $172 billion in 2007 in the United States alone3 (up from $132 billion in 2002)10 and is likely to be greater when the other indirect costs of its associated complications are included.11 These complications are due to atherosclerotic vascular disease4 but also reflect a susceptibility of patients with T2DM . . . [Full Text of this Article]




Related Internet Resources:

Supporting Materials From the American Heart Association

This article has been cited by other articles:


Home page
CirculationHome page
S. Stern and S. Sclarowsky
The ECG in Diabetes Mellitus
Circulation, October 20, 2009; 120(16): 1633 - 1636.
[Full Text] [PDF]